CSIMarket
 
Hims and Hers Health Inc   (NYSE: HIMS)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Hims And Hers Health Inc's Suppliers Performance

HIMS's Supply Chain




 
HIMS Costs vs Sales of Suppliers Growth Hims And Hers Health Inc recorded an increase in cost of sales by 112.82 % year on year, sequentially cost of sales grew by 29.1 % in Q2.

More on HIMS Suppliers



Hims And Hers Health Inc recorded increase in cost of sales by 112.82 % year on year, sequentially cost of sales grew by 29.1 % in Q2.

More on HIMS Suppliers




Hims And Hers Health Inc's Comment on Supply Chain


The company utilizes third-party manufacturers for raw materials and finished product distribution, adhering to current Good Manufacturing Practices (cGMP) to meet standards of identity, strength, quality, and purity. Compliance encompasses organization and training, facilities, equipment, component control, production processes, quality assurance, packaging, labeling, and record-keeping. Any changes to manufacturing equipment, location, or processes require additional regulatory approval. The FDA conducts periodic inspections and may enforce actions for non-compliance. The company monitors FDA compliance among its third-party manufacturers but cannot guarantee consistent adherence. Future products may include controlled substances regulated by the DEA, which mandates registration, record-keeping, labeling, packaging, security measures, and periodic inspections. Non-compliance with DEA regulations can result in criminal and civil penalties.

Hims And Hers Health Inc's Comment on Supply Chain


The company utilizes third-party manufacturers for raw materials and finished product distribution, adhering to current Good Manufacturing Practices (cGMP) to meet standards of identity, strength, quality, and purity. Compliance encompasses organization and training, facilities, equipment, component control, production processes, quality assurance, packaging, labeling, and record-keeping. Any changes to manufacturing equipment, location, or processes require additional regulatory approval. The FDA conducts periodic inspections and may enforce actions for non-compliance. The company monitors FDA compliance among its third-party manufacturers but cannot guarantee consistent adherence. Future products may include controlled substances regulated by the DEA, which mandates registration, record-keeping, labeling, packaging, security measures, and periodic inspections. Non-compliance with DEA regulations can result in criminal and civil penalties.







HIMS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Hims and Hers Health Inc 6,486.57 2,578.49 -142.03 2,442
SUBTOTAL 0.00 0.00 0.00 -


Sources: Hims and Hers Health Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Hims and Hers Health Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.